BNP Paribas Financial Markets’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Hold
0
-$3 4419
2020
Q1
Hold
0
4303
2019
Q4
Sell
-3
Closed -$210 4407
2019
Q3
$163 Hold
3
﹤0.01% 4448
2019
Q2
$134 Buy
3
+1
+50% +$174 ﹤0.01% 4470
2019
Q1
$490 Hold
2
﹤0.01% 4178
2018
Q4
$785 Hold
2
﹤0.01% 3954
2018
Q3
$2.63K Hold
2
﹤0.01% 4222
2018
Q2
$1.94K Sell
2
-26
-93% -$21.6K ﹤0.01% 4257
2018
Q1
$33.2K Hold
28
﹤0.01% 3750
2017
Q4
$26K Buy
28
+16
+133% +$14.8K ﹤0.01% 3913
2017
Q3
$13.7K Sell
12
-1
-8% -$1.14K ﹤0.01% 3774
2017
Q2
$15.4K Buy
+13
New +$15.8K ﹤0.01% 3795

Other funds holding HSTO

BNP Paribas Financial Markets's HSTO Position: Q2 2020 in Review

BNP Paribas Financial Markets held its Histogen Inc. Common Stock (HSTO) position steady in Q2 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4419.

BNP Paribas Financial Markets first reported a position in HSTO in Q2 2017 and has held it in 10 quarters since. The position peaked at $33.2K in Q1 2018. 19 funds tracked by Wall St. Rank hold HSTO as of Q2 2020.

  • BNP Paribas Financial Markets held 0 shares of Histogen Inc. Common Stock worth $0 as of Q2 2020.
  • BNP Paribas Financial Markets left its Histogen Inc. Common Stock share count unchanged in Q2 2020.
  • Histogen Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2020, its #4419 holding.
  • BNP Paribas Financial Markets first reported a position in Histogen Inc. Common Stock in Q2 2017 and has held it in 10 quarters since.
  • BNP Paribas Financial Markets's Histogen Inc. Common Stock position peaked at $33.2K in Q1 2018.
  • 19 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.